Most of the SET molecule is included in the SET-NUP214 fusion protein, and these observations suggest that SET (and possibly also SET-NUP214) associated chemoresistance can be seen in certain cancer cells and include resistance to various anticancer agents. The gene discussed is SET; the disease is cancer.